drugset / Trial / NCT06860620

Efficacy of Zinc Supplementation in Maintaining Sustained Remission in Children With Steroid-sensitive Nephrotic Syndrome

NCT06860620

Completed 192 enrolled Muhammad Aamir Latif
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to fill the gaps by determining the efficacy of zinc supplementation in maintaining sustained remission in children with steroid sensitive nephrotic syndrome (SSNS).

Timeline

Start
2024-01-01
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Zinc Sulfate Unknown 5 mg
Subject Zinc Sulfate Unknown 10 mg
Background Prednisolone Other / unclassified 0.5 mg/kg
Background Prednisolone Other / unclassified 1 mg/kg